News

pfm medical back on the path of growth

The Cologne-based supplier of healthcare solutions, pfm medical, returned to the path of growth in the fiscal year 2017. In the period from 01/01 to 31/12/2017, the pfm medical Group reports revenue of EUR 104.8 million, which reflects an increase of 3.8 per cent compared to the previous year (EUR 100.9 million). At EUR 2.1 million, earnings before interest and taxes (EBIT) were also higher than in 2016 (EUR 1.5 million). The group is setting the...

New: TiLOOP® Bra Pocket – the first synthetic mesh for prepectoral implant-based breast reconstruction

pfm medical expands its product range of titanium-coated mesh implants With the new TiLOOP® Bra Pocket pfm medical becomes the world's only manufacturer to offer a pocket of titanium-coated, synthetic mesh material for prepectoral breast reconstruction, for instance after mastectomy with preservation of skin and nipple. In plastic-esthetic breast surgery, too, it represents a new option for primary or corrective augmentation. Studies on...

Business performance 2016 - pfm medical misses growth targets

The Cologne-based provider of special healthcare solutions, pfm medical, reports revenue of EUR 100.9 million in the fiscal year 2016 (1 January to 31 December 2016), which reflects a decline of 1.2 percent compared to the previous year (EUR 102.1 million). At EUR 1.5 million, earnings before interest and taxes (EBIT) were also lower than in 2015 (EUR 4.1 million). Investments, special factors and currency effects had a negative impact on...

Pelvic floor descent repair with modern mesh implants: The benefits outweigh the acceptable risks

At a press roundtable on 20/04/2017, pfm medical ag and principal investigator Dr. Christian Fünfgeld (Klinik Tettnang GmbH) presented the results of a large, prospective, multicentre trial on surgical repair of genital prolapse with second-generation alloplastic mesh implants. The long-term data, as well as the clinic reports from Tina Cadenbach-Blome (Ev. Amalie-Sieveking Krankenhaus, Hamburg, Germany) and reports from two affected patients,...

Long-term study shows continuous improvement of quality of life following cystocele repair with alloplastic mesh implant

The influence of alloplastic mesh implants (TiLOOP® Total 6) on quality of life, long-term stability and complications in cystocele repair was studied as part of a prospective, multicentre trial. The follow-up on 289 patients over a period of 36 months now confirms that an anatomically stable result was achieved with improved quality of life in all domains measured. Depending on the symptoms, genital prolapse can considerably impair quality of...

Period

pfm medical back on the path of growth

New: TiLOOP® Bra Pocket – the first synthetic mesh for prepectoral implant-based breast reconstruction

Business performance 2016 - pfm medical misses growth targets

Pelvic floor descent repair with modern mesh implants: The benefits outweigh the acceptable risks

Long-term study shows continuous improvement of quality of life following cystocele repair with alloplastic mesh implant